Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial

• Aung Naing,
• Funda Meric-Bernstam,
• Michael Overman,
• Bettzy Stephen,
• David S Hong,
• Sarina A Piha-Paul,
• Daniel D Karp,
• Kanwal P Raghav,
• Dipti Jain,
• Dilichukwu O Chudy Onwugaje,
• Abdulrahman Abonofal,
• Anneleis F Willett,
• Brandon Smaglo,
• Ryan W Huey,
• Gauri R Varadhachary

Affiliations

Aung Naing

Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Funda Meric-Bernstam

Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Michael Overman

Department of Gastrointestinal Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Bettzy Stephen

Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

David S Hong

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA

Sarina A Piha-Paul

Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Daniel D Karp

Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Kanwal P Raghav

Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Dipti Jain

Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Dilichukwu O Chudy Onwugaje

Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Abdulrahman Abonofal

Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Anneleis F Willett

Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Brandon Smaglo

Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Ryan W Huey

Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Gauri R Varadhachary

Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA